Skip to main content
Tessa NewsLink
Paste a health news link, or browse

Source study found

Story checked

Scientists gave worms magnetic bacteria. They lived 43% longer | ScienceDaily (opens in a new tab)

Scientists gave worms magnetic bacteria. They lived 43% longer · 2026-09-24

Short answerEvidenceSource

Short answer

Mixed

Mixed.

One claim goes further than the study.

  • 2 supported
  • 1 overstated

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail
1

The story

Scientists gave worms magnetic bacteria. They lived 43% longer | ScienceDaily

Scientists gave worms magnetic bacteria. They lived 43% longer · 2026-09-24

The story’s checkable claims.

Read the original story (opens in a new tab)
2

NewsLink checks it

Mixed

One claim overstates the study. Two of three check out.

  • 2 supported
  • 1 overstated
Open claim evidence
3
Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

3 claims in this story

Showing all 3 claimsChoose a verdict to focus the list.

Claim 1 of 3OverstatedThe article says the main mechanism appears to be suppression of ferroptosis, with reduced iron buildup and lipid peroxidation, and that magnetosome production played a major role in the longevity effect.View evidenceHide evidence

Why this verdict

The abstract-level profile supports reduced Fe2+ content, reduced lipid peroxide levels, altered ferroptosis-related gene expression, and an author interpretation that AMB-1 attenuated aging-associated ferroptosis. However, framing ferroptosis as the 'main mechanism' is stronger than the abstract details can establish, and the profile does not verify that magnetosome production played a major role in the longevity effect. RNAi evidence for ads-1 is reported, but quantitative and design details are not available at abstract depth.

1

Study evidence

AMB-1 feeding decreased Fe2+ content relative to OP50-fed controls.34.11% decrease

“AMB-1 treatment decreased Fe2+ content by 34.11 % and lipid peroxide levels by 52.19 %, compared to the OP50-fed control”
2

Study evidence

RNAi knockdown of the ferroptosis-related gene ads-1 altered the longevity response to AMB-1 feeding; the authors report that ads-1 played a critical role in AMB-1-induced lifespan extension.

“RNA interference (RNAi) experiments revealed that the ferroptosis-related gene ads-1... played a critical role in AMB-1-induced longevity”
Claim 2 of 3SupportedResearchers led by Prof. An Xu found that the magnetotactic bacterium Magnetospirillum magneticum AMB-1 can extend healthy lifespan in Caenorhabditis elegans.View evidenceHide evidence

As statedhealthy lifespan extended

Why this verdict

The abstract-level profile supports that feeding C. elegans with Magnetospirillum magneticum AMB-1 extended lifespan and healthspan, including neural function and intestinal integrity. The profile does not independently verify the named lead researcher, but the scientific substance of the claim is supported at abstract depth.

1

Study evidence

Feeding C. elegans AMB-1 increased mean lifespan by 43.39%, from 17.17 ± 1.25 to 24.62 ± 1.44 days compared with OP50-fed controls.43.39% increase (mean lifespan)

“feeding with AMB-1 significantly extended the mean lifespan of C. elegans by 43.39 %, from 17.17 ± 1.25 to 24.62 ± 1.44 days”
Claim 3 of 3SupportedWorms treated with AMB-1 lived substantially longer, with average lifespan increasing by 43.39%, while neurological function and intestinal integrity were also preserved in older worms.View evidenceHide evidence

As stated43.39%

Why this verdict

The profile reports the same mean lifespan increase, 43.39%, from 17.17 ± 1.25 to 24.62 ± 1.44 days, and states that AMB-1 improved neural function and preserved intestinal integrity in aged C. elegans. Because this was an experimental feeding intervention in worms, the causal framing is supported for the C. elegans model.

1

Study evidence

Feeding C. elegans AMB-1 increased mean lifespan by 43.39%, from 17.17 ± 1.25 to 24.62 ± 1.44 days compared with OP50-fed controls.43.39% increase (mean lifespan)

“feeding with AMB-1 significantly extended the mean lifespan of C. elegans by 43.39 %, from 17.17 ± 1.25 to 24.62 ± 1.44 days”
Then look for missing context

Context layer

What the story left out

Important study details the story did not include.

  • Ferroptosis-related gene evidence included ftn-1 upregulation, bli-3 downregulation, and RNAi evidence that ads-1 is critical for AMB-1-induced longevity.

    The story mentions ferroptosis generally and attributes a role to magnetosome production, but it does not reflect the specific gene-expression and ads-1 RNAi evidence described in the abstract-level profile.

    From in_vivo_animal feeding intervention; biochemical and molecular assays; C. elegans ads-1 RNAi during AMB-1 dietary interv

  • The form, dose, and conditions of AMB-1 exposure, including live versus killed bacteria and possible general dietary effects, are not specified at abstract depth.

    The story does not mention these intervention-design uncertainties, which matter for interpreting what aspect of AMB-1 caused the observed longevity effect.

    From in vivo C. elegans dietary intervention; lifespan and healthspan assays

4 things the story did carry across
  • AMB-1 feeding extended C. elegans lifespan and healthspan, including neural function and intestinal integrity.
  • The reported mean lifespan increase was 43.39% versus OP50-fed controls.
  • AMB-1 was associated with suppression of aging-associated ferroptosis, including reduced Fe2+ and lipid peroxidation.
  • The evidence is from C. elegans basic research and does not demonstrate clinical anti-aging use in humans.
Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

3

Evidence read

study summary

Lead result

in vivo animal

1Lead resultin vivo animalFeeding C. elegans with Magnetospirillum magneticum AMB-1 extends lifespan and healthspan (neural function and intestinal integrity).in vivo C. elegans dietary intervention; lifespan and healthspan assaysExpand

In plain English

In C. elegans, dietary feeding with Magnetospirillum magneticum AMB-1 (vs OP50) increased mean lifespan by 43.39% and improved measures of neural function and intestinal integrity, consistent with a healthy lifespan extension reported in the abstract.

Key findings

  • Feeding C. elegans AMB-1 increased mean lifespan by 43.39%, from 17.17 ± 1.25 to 24.62 ± 1.44 days compared with OP50-fed controls.43.39% increase (mean lifespan)
  • AMB-1 improved neural function and preserved intestinal integrity in aged C. elegans, described by the authors as contributing to a significant healthy lifespan extension.
“feeding with AMB-1 significantly extended the mean lifespan of C. elegans by 43.39 %, from 17.17 ± 1.25 to 24.62 ± 1.44 days”
What this piece can’t prove
  • Summary is based on abstract text only; the abstract lacks many experimental details (sample sizes, statistical analyses, assay protocols, and exact experimental conditions).

2 further details could not be confirmed from the summary.

2in vivo animalAMB-1 suppresses age-associated ferroptosis in C. elegans (reduced Fe2+ and lipid peroxidation; modulation of ferroptosis-related genes ftn-1 and bli-3).in vivo animal feeding intervention; biochemical and molecular assaysExpand

In plain English

In C. elegans fed the magnetotactic bacterium Magnetospirillum magneticum AMB-1 versus standard OP50, the authors report reduced iron(II) content and decreased lipid peroxidation together with gene expression shifts (ftn-1 up, bli-3 down) and overall attenuation of aging-associated ferroptosis; RNAi against the ferroptosis-related gene ads-1 was reported to be required for the AMB-1–linked longevity effect.

Key findings

  • AMB-1 feeding decreased Fe2+ content relative to OP50-fed controls.34.11% decrease
  • AMB-1 feeding decreased lipid peroxide levels relative to OP50-fed controls.52.19% decrease
“AMB-1 treatment decreased Fe2+ content by 34.11 % and lipid peroxide levels by 52.19 %, compared to the OP50-fed control”
What this piece can’t prove

5 further details could not be confirmed from the summary.

3in vivo animalThe ferroptosis-related gene ads-1 is required for AMB-1-induced longevity, as shown by RNAi experiments.C. elegans ads-1 RNAi during AMB-1 dietary intervention with lifespan assessmentExpand

In plain English

RNA interference targeting the ferroptosis-related gene ads-1 (encoding AGPS) was used to test whether ads-1 is required for the lifespan extension produced by feeding C. elegans with Magnetospirillum magneticum AMB-1. The authors report that ads-1 played a "critical role" in AMB-1-induced longevity based on these RNAi experiments.

Key findings

  • RNAi knockdown of the ferroptosis-related gene ads-1 altered the longevity response to AMB-1 feeding; the authors report that ads-1 played a critical role in AMB-1-induced lifespan extension.
“RNA interference (RNAi) experiments revealed that the ferroptosis-related gene ads-1... played a critical role in AMB-1-induced longevity”
What this piece can’t prove

3 further details could not be confirmed from the summary.

Finally, the search trail

Method layer

NewsLink found the paper. Tessa takes you deeper.

NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.

Papers considered

The selected paper, plus nearby candidates.

PubMed, Europe PMC, Crossref · 22 candidate papers

Candidate

Corrigendum to "Fibroblast growth factor receptor inhibitors ameliorate metabolic dysfunction-associated steatohepatitis by modulating the glycine-glutathione-gut microbiota axis" [Free Rad. Biol. Med. 240 (2025) 410-425].

Free Radical Biology & Medicine · 2026 · PubMed, Crossref

Tessa (opens in a new tab)Source (opens in a new tab)

And 16 more candidates considered.